O2 RegenTech Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 9

O2 RegenTech General Information


Developer of a wound care technology designed to prevent and cure infections. The company's proprietary and patented product OXAID™ uses biopolymer technology as an oxygenating, moist, and antimicrobial dressing to promote chronic wound healing, thereby, providing cost-effective and easy-to-use wound care solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 411 Wolf Ledges Parkway
  • Suite 100
  • Akron, OH 44311
  • United States

O2 RegenTech Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

O2 RegenTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 11-Jul-2021 0000 Completed Generating Revenue
9. Equity Crowdfunding Cancelled Generating Revenue
8. Accelerator/Incubator 02-Jun-2020 0000 Completed Startup
7. Grant 01-Jan-2018 00000 0000 Completed Startup
6. Grant 27-Jun-2017 00000 0000 Completed Startup
5. Grant 26-Jan-2017 00000 0000 Completed Startup
4. Grant 0000 0000 Completed Startup
3. Grant 18-Dec-2015 00000 0000 Completed Startup
2. Accelerator/Incubator 29-Jun-2015 $25K $25K Completed Startup
1. Grant 17-Jun-2015 $10K Completed Startup
To view O2 RegenTech’s complete valuation and funding history, request access »

O2 RegenTech Executive Team (2)

Name Title Board Seat Contact Info
Andreas Inmann Co-Founder, Chief Executive Officer & President
Nic Leipzig Co-Founder & Chief Technology Officer
To view O2 RegenTech’s complete executive team members history, request access »

O2 RegenTech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

O2 RegenTech Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Astralabs Accelerator/Incubator Minority 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government Minority 000 0000 000000 0
Ohio Third Frontier Corporation 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »